Deoxycitidine Kinase Is Associated With Prolonged Survival After Adjuvant Gemcitabine for Resected Pancreatic Adenocarcinoma

Cancer - United States
doi 10.1002/cncr.25303
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

A Case Report of Gemcitabine-Induced Steatohepatitis Associated With Adjuvant Monotherapy for Pancreatic Adenocarcinoma

The Medicine Forum
2017English

Adjuvant Chemotherapy Followed by Concurrent Chemoradiation Is Associated With Improved Survival for Resected Stage I-Ii Pancreatic Cancer

Cancer Medicine
Cancer ResearchNuclear MedicineRadiologyImagingOncology
2019English

EGFR, but Not COX‑2, Protein in Resected Pancreatic Ductal Adenocarcinoma Is Associated With Poor Survival

Oncology Letters
Cancer ResearchOncology
2019English

Adjuvant Chemotherapy With Gemcitabine and Long-Term Outcomes Among Patients With Resected Pancreatic Cancer

JAMA - Journal of the American Medical Association
Medicine
2013English

Extracellular Lumican Inhibits Pancreatic Cancer Cell Growth and Is Associated With Prolonged Survival After Surgery

Clinical Cancer Research
Cancer ResearchOncology
2014English

Adjuvant Chemotherapy Versus Chemoradiation for Patients With Resected Pancreatic Adenocarcinoma: A Single-Center Retrospective Study

The Korean Journal of Pancreas and Biliary Tract
2018English

Neo-Adjuvant Cheomoradiation Therapy for Pancreatic Cancer Is Associated With Adverse Outcome After Pancreaticoduodectomy.

HPB
HepatologyGastroenterology
2018English

Increased Neutrophil-To-Lymphocyte Ratio After Neoadjuvant Therapy Is Associated With Worse Survival After Resection of Borderline Resectable Pancreatic Ductal Adenocarcinoma

Surgery
Surgery
2016English

Factors Associated With Better Survival in Patients Undergoing Pancreaticoduodenectomy for Pancreatic Adenocarcinoma

HPB
HepatologyGastroenterology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy